# Prognostic value of the creatinine-to-albumin ratio for 28-day mortality in patients with sepsis and diabetes: integrating renal and nutritional status in the ICU

**Authors:** Jianzhu Zhou, Hui Qiu, Jiahui Li, Jiamiao Liu, Chengxian Guo

PMC · DOI: 10.3389/fnut.2026.1724997 · 2026-02-03

## TL;DR

The study shows that a high creatinine-to-albumin ratio is linked to higher mortality in ICU patients with sepsis and diabetes, suggesting it could help predict outcomes.

## Contribution

This study identifies the creatinine-to-albumin ratio as a novel prognostic marker for 28-day mortality in ICU patients with sepsis and diabetes.

## Key findings

- Patients in the highest CAR quartile had a 4.68-fold greater risk of 28-day mortality.
- CAR had an AUC of 0.664 for predicting mortality and was strongly associated with mortality in the norepinephrine group.
- Higher CAR was linked to longer ICU length of stay.

## Abstract

Patients with sepsis and diabetes exhibit complex pathophysiology that greatly increases the risk of adverse outcomes. This study aimed to investigate the association between CAR and 28-day all-cause mortality among intensive care unit (ICU) patients with sepsis and diabetes mellitus.

In this retrospective cohort study based on the eICU-CRD, we analyzed 1,800 adult patients with sepsis and diabetes mellitus, who were stratified into quartiles by admission CAR. Survival was assessed by Kaplan–Meier analysis. Covariates were selected via LASSO and stepwise regression. Multivariate Cox models evaluated CAR’s independent association with mortality. Restricted cubic splines explored nonlinear relationships. ROC analysis and subgroup analyses were performed.

Multivariate Cox proportional hazards analysis indicated that CAR was significantly correlated with the 28-day mortality risk in the ICU. Patients in the highest quartile (Q4) had a 4.68-fold greater risk of death compared with those in the lowest quartile [HR 4.68, 95% CI 2.55–8.61, p < 0.001]. CAR had an AUC of 0.664 for mortality prediction and was associated with a higher mortality risk in the norepinephrine group [HR 8.26, 95% CI 2.55–26.76, p < 0.001]. Higher CAR was also associated with a longer ICU length of stay (β = 1.06, p = 0.006).

CAR was associated with increased 28-day mortality in ICU patients with sepsis and diabetes. These findings suggest that CAR may be useful for prognosis assessment and risk stratification.

## Linked entities

- **Diseases:** diabetes mellitus (MONDO:0005015)

## Full-text entities

- **Genes:** CXADRP1 (CXADR pseudogene 1) [NCBI Gene 653108] {aka CAR, CXADRP}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** acute pulmonary embolism (MESH:D011655), septic shock (MESH:D012772), Metabolic (MESH:D008659), renal perfusion (MESH:D006030), renal ischemia (MESH:D007511), immune dysregulation (OMIM:614878), inflammatory dysregulation (MESH:D021081), hypoxia (MESH:D000860), Sepsis (MESH:D018805), kidney injury (MESH:D007674), Organ Failure (MESH:D009102), type 1 and type 2 diabetes (MESH:D003924), dysfunction (MESH:D006331), Acute kidney injury (MESH:D058186), COPD (MESH:D029424), endocrine disturbances (MESH:D004700), metastatic cancer (MESH:D009369), Diabetes (MESH:D003920), endothelial dysfunction (MESH:D014652), SIRS (MESH:D018746), infection (MESH:D007239), CKD (MESH:D012080), renal insufficiency (MESH:D051437), chronic kidney disease (MESH:D051436), hyperglycemia (MESH:D006943), critically ill (MESH:D016638), metabolic disturbances (MESH:D024821), microvascular damage (MESH:D017566), inflammation (MESH:D007249), coronary heart disease (MESH:D003327), leukemia (MESH:D007938), death (MESH:D003643), hypertension (MESH:D006973)
- **Chemicals:** norepinephrine (MESH:D009638), insulin (MESH:D007328), blood glucose (MESH:D001786), nitric oxide (MESH:D009569), glucose (MESH:D005947), Cr (MESH:D003404), urea nitrogen (MESH:C530477), bilirubin (MESH:D001663), lactate (MESH:D019344), alpha-adrenergic (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12909246/full.md

---
Source: https://tomesphere.com/paper/PMC12909246